Literature DB >> 16785107

Muscle fiber orientation in muscles commonly injected with botulinum toxin: an anatomical pilot study.

S Deshpande1, M E Gormley, J R Carey.   

Abstract

The endplate zone is assumed to be at about the midpoint of a muscle fiber. This study was designed to locate the middle of the muscle fibers of commonly injected muscles, thus identifying the endplate zone of these muscles. The proximal and distal musculotendinous junctions in muscles of the upper and lower extremities were identified. Orientation of muscle fibers was determined. Measurements using common surface landmarks were used to determine the relationship of these muscles with the landmarks (e.g., biceps muscle bulk extends from the upper fourth to the lower fourth of the humerus). Figures were developed using these measurements so as to be able to extrapolate these measurements to other patients of varying sizes. Illustrations of muscle fiber orientation were done and the assumed location of motor endplate bands marked. Color illustrations will be shown. With the thought that the endplate zone is at the middle of the muscle fiber, this detailed study of muscle fibers helps identify assumed location of motor endplates of specific muscles, thereby improving technique and efficacy of botulinum toxin injections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785107     DOI: 10.1007/bf03033928

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  18 in total

1.  Structural organization of the motor nerve endings in mammalian muscle spindles and other striated muscle fibers.

Authors:  C COERS
Journal:  Am J Phys Med       Date:  1959-08

Review 2.  Targeting the neuromuscular junction in skeletal muscles.

Authors:  Martin K Childers
Journal:  Am J Phys Med Rehabil       Date:  2004-10       Impact factor: 2.159

Review 3.  Injection techniques for botulinum toxin using electromyography and electrical stimulation.

Authors:  C F O'Brien
Journal:  Muscle Nerve Suppl       Date:  1997

4.  Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.

Authors:  G E Borodic; R Ferrante; L B Pearce; K Smith
Journal:  Mov Disord       Date:  1994-01       Impact factor: 10.338

5.  Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.

Authors:  Marc Rousseaux; Odile Kozlowski; Jérome Froger
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

6.  Ultrasound-guided botulinum toxin injection technique for the iliopsoas muscle.

Authors:  Bettina Westhoff; Konrad Seller; Alexander Wild; Marcus Jaeger; Ruediger Krauspe
Journal:  Dev Med Child Neurol       Date:  2003-12       Impact factor: 5.449

7.  Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.

Authors:  C M Shaari; I Sanders
Journal:  Muscle Nerve       Date:  1993-09       Impact factor: 3.217

8.  Successful treatment of childhood spasticity secondary to cerebral palsy using Botox.

Authors:  Chandler Gill; Cassondra Covington; Bimal Padaliya; William Newman; Terri Pomeroy; P David Charles
Journal:  Tenn Med       Date:  2003-11

Review 9.  Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.

Authors:  L Andrew Koman; Beth Paterson Smith; Rajesh Balkrishnan
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 10.  [EMG support in botulinum toxin treatment].

Authors:  G Monnier; B Parratte; L Tatu; A Cosson; F Michel; G Metton
Journal:  Ann Readapt Med Phys       Date:  2003-07
View more
  6 in total

1.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

3.  Localization of motor entry points and terminal intramuscular nerve endings of the musculocutaneous nerve to biceps and brachialis muscles.

Authors:  Je-Hun Lee; Hye-Won Kim; Sun Im; Xiaochun An; Mi-Sun Lee; U-Young Lee; Seung-Ho Han
Journal:  Surg Radiol Anat       Date:  2009-09-25       Impact factor: 1.246

4.  Surface mapping of motor points in biceps brachii muscle.

Authors:  Ja-Young Moon; Tae-Sun Hwang; Seon-Ju Sim; Sae-Il Chun; Minyoung Kim
Journal:  Ann Rehabil Med       Date:  2012-04-30

Review 5.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

6.  Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation.

Authors:  Lucia Cosenza; Alessandro Picelli; Danila Azzolina; Marco Alessandro Minetto; Marco Invernizzi; Michele Bertoni; Andrea Santamato; Alessio Baricich
Journal:  Toxins (Basel)       Date:  2020-07-31       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.